Literature DB >> 444313

Immune complexes in rheumatoid arthritis sera and synovial fluids: a comparison of three methods.

J T Halla, J E Volanakis, R E Schrohenloher.   

Abstract

Sera and synovial fluids from 88 patients with rheumatoid arthritis were examined for circulating immune complexes by three assays: monoclonal rheumatoid factor radioimmunoassay, C1q binding assay, and Raji cell radioassay. Paired samples were available for 82 patients. Immune complexes were detected with high frequency in the synovial fluid by each assay (75% by the monoclonal rheumatoid factor radioimmunoassay, 95% by the C1q binding assay, and 61% by the Raji cell readioassay). In rheumatoid arthritis sera, immune complexes were detected with high frequency by the C1q binding assay (85%) and the monoclonal rheumatoid factor radioimmunoassay (70%) but infrequently by the Raji cell radioassay (26%). The presence of immune complexes in serum was most frequently accompanied by the presence of complexes in fluid, regardless of the method of detection; moreover, the levels of immune complexes in synovial fluid were generally higher than in paired serum. Further, the levels of immune complexes as measured by the C1q binding assay correlated with certain parameters of clinical activity, while the monoclonal rheumatoid factor radioimmunoassay and Raji cell radioassay correlated with extraarticular features (excluding nodules) of rheumatoid arthritis.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 444313     DOI: 10.1002/art.1780220502

Source DB:  PubMed          Journal:  Arthritis Rheum        ISSN: 0004-3591


  20 in total

1.  Immunoglobulin isotype composition of circulating and intra-articular immune complexes in patients with inflammatory joint disease.

Authors:  A D Crockard; J M Thompson; M B Finch; T A McNeill; A L Bell; S D Roberts
Journal:  Rheumatol Int       Date:  1991       Impact factor: 2.631

2.  Mast cells contribute to initiation of autoantibody-mediated arthritis via IL-1.

Authors:  Peter A Nigrovic; Bryce A Binstadt; Paul A Monach; Alyssa Johnsen; Michael Gurish; Yoichiro Iwakura; Christophe Benoist; Diane Mathis; David M Lee
Journal:  Proc Natl Acad Sci U S A       Date:  2007-02-02       Impact factor: 11.205

Review 3.  Impact of gut microbiota on gut-distal autoimmunity: a focus on T cells.

Authors:  Maran L Sprouse; Nicholas A Bates; Krysta M Felix; Hsin-Jung Joyce Wu
Journal:  Immunology       Date:  2019-01-21       Impact factor: 7.397

4.  Circulating immune complexes and rheumatoid arthritis: a comparison of different assay methods and their early predictive value for disease activity and outcome.

Authors:  J S Reeback; A J Silman; E J Holborow; R N Maini; F C Hay
Journal:  Ann Rheum Dis       Date:  1985-02       Impact factor: 19.103

Review 5.  Immune complexes in human diseases: a review.

Authors:  A N Theofilopoulos; F J Dixon
Journal:  Am J Pathol       Date:  1980-08       Impact factor: 4.307

Review 6.  Antibody-dependent and -independent mechanisms of inflammatory arthritis.

Authors:  Margaret H Chang; Peter A Nigrovic
Journal:  JCI Insight       Date:  2019-03-07

7.  IgG rheumatoid factor, complement and immune complexes in rheumatoid synovitis and vasculitis: comparative and serial studies during cytotoxic therapy.

Authors:  D G Scott; P A Bacon; C Allen; C J Elson; T Wallington
Journal:  Clin Exp Immunol       Date:  1981-01       Impact factor: 4.330

8.  Self-associating IgG rheumatoid factors stimulate monocytes to release prostaglandins and mononuclear cell factor that stimulates collagenase and prostaglandin production by synovial cells.

Authors:  F A Nardella; J M Dayer; M Roelke; S M Krane; M Mannik
Journal:  Rheumatol Int       Date:  1983       Impact factor: 2.631

9.  Serum immune complexes containing IgA appear to predict erosive arthritis in a longitudinal study in rheumatoid arthritis.

Authors:  M L Westedt; M R Daha; W M Baldwin; T Stijnen; A Cats
Journal:  Ann Rheum Dis       Date:  1986-10       Impact factor: 19.103

10.  Waldenström's hyperglobulinemic purpura: an unusual immune complex disorder.

Authors:  A Pines; I Ben-Bassat
Journal:  Clin Rheumatol       Date:  1984-06       Impact factor: 2.980

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.